Showing results (251-260 of 276) with videos related to

Sort By:
Pageof 28
Surgical Oncology|November 9, 2017
The role of intestinal bacteria in the development and progression of gastrointestinal tract neoplasmsKosuke Mima, Shuji Ogino, Shigeki Nakagawa, et al.
Annals of Surgical Oncology|February 19, 2015
Molecular Characteristics of Basaloid Squamous Cell Carcinoma of the Esophagus: Analysis of KRAS, BRAF, and PIK3CA Mutations and LINE-1 MethylationYoshifumi Baba, Takatsugu Ishimoto, Kazuto Harada, et al.
The Annals of Thoracic Surgery|January 22, 2021
Prognostic Impact of PD-1 on Tumor-Infiltrating Lymphocytes in 433 Resected Esophageal CancersDaichi Nomoto, Yoshifumi Baba, Kazuo Okadome, et al.
British Journal of Cancer|January 4, 2023
Intratumour Fusobacterium nucleatum and immune response to oesophageal cancerKeisuke Kosumi, Yoshifumi Baba, Kensuke Yamamura, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|August 21, 2023
High Pretreatment Mean Corpuscular Volume Can Predict Worse Prognosis in Patients With Esophageal Squamous Cell Carcinoma who Have Undergone Curative Esophagectomy: A Retrospective Multicenter Cohort StudyNaoya Yoshida, Ken Sasaki, Kengo Kanetaka, et al.
Surgery Today|October 10, 2014
A clinicopathological analysis of primary mucosal malignant melanomaDaisuke Izumi, Takatsugu Ishimoto, Naoya Yoshida, et al.
BMC Cancer|July 9, 2016
Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature reviewKazuto Harada, Yoshifumi Baba, Hironobu Shigaki, et al.
International Journal of Cancer|August 5, 2015
Lysine-specific demethylase-1 contributes to malignant behavior by regulation of invasive activity and metabolic shift in esophageal cancerKeisuke Kosumi, Yoshifumi Baba, Akihisa Sakamoto, et al.
British Journal of Cancer|March 27, 2020
Prognostic and clinical impact of PD-L2 and PD-L1 expression in a cohort of 437 oesophageal cancersKazuo Okadome, Yoshifumi Baba, Daichi Nomoto, et al.
British Journal of Cancer|October 26, 2020
Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancerKohei Yamashita, Masaaki Iwatsuki, Noriko Yasuda-Yoshihara, et al.
Pageof 28